Older people Not Applicable
Conditions
Interventions
Intentional non-adherence will be ascertained by questionnaire and intentionally non-adherent participants will be excluded from the randomised controlled trial (RCT). Full adherence will be measured
Sponsors
University of East Anglia (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 75 years or over 2. Are prescribed three or more solid oral dose form medications for the management of a chronic condition 3. Have a life expectancy equal to or in excess of one year 4. Are capable of providing informed consent
Exclusion criteria
Exclusion criteria: 1. Participants in receipt of a prescribed medication organisation device or with a history of having received amedication organisation device 2. Are resident in a care home 3. Are currently or have recently been involved in medication intervention trials 4. Have been diagnosed with Parkinson's disease 5. Have a severe mental health disorder such as schizophrenia or other clinical contraindications which in the opinion of the healthcare team renders the patient inappropriate for trial participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication taking events will be measured using proprietary electronic films and results compared for pill boxes and usual supply and weekly and 4-weekly medication supply. | — |
Secondary
| Measure | Time frame |
|---|---|
| Unintentionally non-adherent RCT trial participants will be characterised using tests of visual acuity, finger dexterity and cognitive ability. These aspects are likely to be particularly important in the study population and results will be compared for medication organisation devices and usual packaging for monthly or weekly supply to ascertain differences. Participant satisfaction with their method of medication supply, participant perceived autonomy, quality of life data and carers' views on the effects of the medication supply on them and their caring routines will be measured using questionnaire-based tools. Health care utilisation during the period of the study will be assessed using Healthcare Episode Statistics and GP-provided data. Where applicable, results will be compared for pill boxes and usual packaging for monthly or weekly supply to ascertain differences. Information pertaining to health economics (quality of life and healthcare utilisation) will be used to determine cost effectiveness. In addition, views on acceptability, patient autonomy and quality of life in the study population and cost effectiveness will also be used to inform future study design. | — |
Countries
United Kingdom
Outcome results
None listed